Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Gram

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|May 1, 1975
First-pass metabolism of imipramine in manL F Gram, J Christiansen
European Journal of Clinical Pharmacology|January 1, 1989
Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramineK Brøsen, L F Gram
European Journal of Clinical Pharmacology|January 1, 1989
Clinical significance of the sparteine/debrisoquine oxidation polymorphismK Brøsen, L F Gram
Pharmacopsychiatry|January 1, 1986
Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity?L F Gram, P Christensen
Ugeskrift for Laeger|June 2, 1975
[Editorial: Reporting of drug side effects]L F Gram, A Pedersen
Psychopharmacology Series|January 1, 1989
Pharmacokinetic and clinical significance of genetic variability in psychotropic drug metabolismK Brøsen, L F Gram
Acta Psychiatrica Scandinavica|January 1, 1972
Lithium treatment of psychotic children and adolescents. A controlled clinical trialL F Gram, O J Rafaelsen
Lancet (London, England)|May 19, 1973
Drugs and the Common MarketO J Rafaelsen, L F Gram
British Medical Journal|February 19, 1972
Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in manL F Gram, K F Overo
Clinical Pharmacology and Therapeutics|September 1, 1975
First-pass metabolism of nortriptyline in manL F Gram, K F Overo
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|May 1, 1975
First-pass metabolism of imipramine in manL F Gram, J Christiansen
European Journal of Clinical Pharmacology|January 1, 1989
Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramineK Brøsen, L F Gram
European Journal of Clinical Pharmacology|January 1, 1989
Clinical significance of the sparteine/debrisoquine oxidation polymorphismK Brøsen, L F Gram
Pharmacopsychiatry|January 1, 1986
Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity?L F Gram, P Christensen
Ugeskrift for Laeger|June 2, 1975
[Editorial: Reporting of drug side effects]L F Gram, A Pedersen
Psychopharmacology Series|January 1, 1989
Pharmacokinetic and clinical significance of genetic variability in psychotropic drug metabolismK Brøsen, L F Gram
Acta Psychiatrica Scandinavica|January 1, 1972
Lithium treatment of psychotic children and adolescents. A controlled clinical trialL F Gram, O J Rafaelsen
Lancet (London, England)|May 19, 1973
Drugs and the Common MarketO J Rafaelsen, L F Gram
British Medical Journal|February 19, 1972
Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in manL F Gram, K F Overo
Clinical Pharmacology and Therapeutics|September 1, 1975
First-pass metabolism of nortriptyline in manL F Gram, K F Overo
Pageof 20